Global Dental Bone Graft Substitutes and other Biomaterials Market Size By Type (Synthetic Bone Grafts, Xenografts), By Application (Hospitals, Ambulatory Surgical Centers (ASCs)), By Region, And Segm...

Report Id: 21978 | Published Date: Mar 2025 | No. of Pages: | Base Year for Estimate: Mar 2025 | Format:


The Global Dental Bone Graft Substitutes and Other Biomaterials Market was valued at USD 3.2 billion in 2023 and is projected to surpass USD 6.5 billion by 2031, growing at a CAGR of 9.4% during the forecast period from 2023 to 2031. The market is primarily driven by the increasing prevalence of dental disorders, rising adoption of dental implants, technological advancements in biomaterials, and growing awareness regarding oral health.

Dental bone graft substitutes and biomaterials play a crucial role in restoring lost bone structure, enhancing implant success rates, and improving overall oral health. The increasing geriatric population, who are more prone to periodontal diseases and tooth loss, further accelerates market demand. Additionally, minimally invasive procedures and the rising preference for synthetic and xenograft materials are expected to shape the market dynamics during the forecast period.

Market Drivers

1. Growing Prevalence of Dental Disorders

The increasing incidence of periodontal diseases, dental caries, and edentulism has propelled the demand for dental bone graft substitutes and biomaterials. According to the WHO, nearly 3.5 billion people worldwide suffer from oral diseases, creating a substantial market opportunity.

2. Rising Adoption of Dental Implants

With the growing acceptance of cosmetic dentistry and improved affordability of dental implants, more patients are opting for bone grafting procedures to support implants, fueling market expansion.

3. Advancements in Biomaterials Technology

Innovations in biocompatible and synthetic bone graft materials are leading to more effective and long-lasting dental solutions. Advanced materials such as calcium phosphate-based grafts, growth factor-infused grafts, and nanotechnology-enhanced biomaterials are gaining traction.

Market Restraints

1. High Cost of Dental Procedures

Despite advancements, high treatment costs and lack of reimbursement policies in some regions hinder market penetration. The expensive nature of dental implants and grafting procedures makes them inaccessible to a significant portion of the population.

2. Limited Awareness in Developing Regions

In emerging markets, low awareness about oral healthcare and affordability constraints limit the adoption of advanced dental procedures, restraining market growth.

Market Opportunities

1. Increasing Demand for Synthetic Bone Grafts

The shift toward synthetic and xenograft-based dental biomaterials due to their availability, reduced risk of disease transmission, and biocompatibility presents significant growth potential.

2. Rising Focus on Minimally Invasive Procedures

The demand for minimally invasive bone grafting techniques, such as socket preservation procedures and growth factor-based regenerative treatments, is expected to drive the market in the coming years.

3. Expansion in Emerging Markets

Asia-Pacific and Latin America are anticipated to witness substantial growth due to rising dental tourism, increasing disposable income, and improving healthcare infrastructure.

Market by Material Type Insights

Based on material type, the Synthetic Bone Graft segment accounted for the largest market share in 2023. Calcium phosphate, bioactive glass, and polymer-based grafts are increasingly preferred due to their biocompatibility, affordability, and easy availability. This segment is expected to maintain its dominance due to continuous advancements in bioengineered bone grafts.

Market by End-use Insights

The Dental Clinics segment dominated the market in 2023, holding more than 50% of the market share. The increasing number of private dental practices, along with the growing preference for implantology procedures in outpatient settings, is driving this segment. Hospitals and academic institutions are also playing a crucial role in dental research and advanced regenerative therapies.

Market by Regional Insights

1. North America

North America held the largest market share in 2023, driven by high awareness about oral healthcare, advanced dental infrastructure, and the presence of key market players. The U.S. and Canada continue to lead due to favorable reimbursement policies and technological innovations in biomaterials.

2. Europe

Europe remains a key market, with Germany, France, and the UK at the forefront due to a growing geriatric population, rising dental implant procedures, and government initiatives for oral healthcare.

3. Asia-Pacific

Asia-Pacific is expected to register the highest CAGR during the forecast period, led by China, India, Japan, and South Korea. Rising disposable incomes, expanding dental tourism, and increasing investment in dental healthcare infrastructure are the major growth drivers.

Competitive Scenario

Key players in the Global Dental Bone Graft Substitutes and Other Biomaterials Market include:

Zimmer Biomet

Medtronic

Dentsply Sirona

Straumann Group

Geistlich Pharma AG

BioHorizons

Botiss Biomaterials GmbH

NovaBone Products, LLC

RTI Surgical, Inc.

Olympus Terumo Biomaterials Corp.

These companies are investing in R&D, forming strategic collaborations, and launching advanced biomaterials to strengthen their market position. Recent advancements include growth factor-infused bone grafts and 3D-printed bioresorbable scaffolds for dental applications.

Scope of Work – Global Dental Bone Graft Substitutes and Other Biomaterials Market

Report Metric

Details

Market Size (2023)

USD 3.2 billion

Projected Market Size (2031)

USD 6.5 billion

CAGR (2023-2031)

9.4%

Key Segments

Material Type, End-use, Region

Largest Market Segment

Synthetic Bone Grafts

Leading End-use Segment

Dental Clinics

Key Regions

North America, Europe, Asia-Pacific

Major Companies

Zimmer Biomet, Medtronic, Dentsply Sirona, Geistlich Pharma AG, Straumann Group

Growth Drivers

Rising prevalence of dental disorders, increasing adoption of dental implants, technological advancements in biomaterials

Market Opportunities

Increasing demand for synthetic bone grafts, expansion in emerging markets, advancements in minimally invasive techniques

Key Market Developments

Zimmer Biomet launched a new range of collagen-based and synthetic bone grafts in 2023, focusing on enhanced bioactivity and faster healing.

Straumann Group partnered with a leading biotechnology firm in 2024 to develop next-generation bioresorbable scaffolds for bone regeneration.

Geistlich Pharma AG expanded its product portfolio in 2023 with growth factor-infused bone substitutes, targeting enhanced tissue integration and osseointegration.

FAQs

1. What is the current market size of the Global Dental Bone Graft Substitutes and Other Biomaterials Market?

The market was valued at USD 3.2 billion in 2023 and is expected to grow significantly in the coming years.

2. What is the major growth driver of the Global Dental Bone Graft Substitutes and Other Biomaterials Market?

The primary growth drivers include the increasing prevalence of dental disorders, rising adoption of dental implants, and technological advancements in biomaterials.

3. Which is the largest region during the forecast period in the Global Dental Bone Graft Substitutes and Other Biomaterials Market?

North America holds the largest market share, followed by Europe. However, Asia-Pacific is expected to witness the fastest growth during the forecast period.

4. Which segment accounted for the largest market share in the Global Dental Bone Graft Substitutes and Other Biomaterials Market?

The Synthetic Bone Grafts segment accounted for the largest market share in 2023 due to their superior biocompatibility and increasing adoption in implant procedures.

5. Who are the key market players in the Global Dental Bone Graft Substitutes and Other Biomaterials Market?

Key players include Zimmer Biomet, Medtronic, Dentsply Sirona, Straumann Group, Geistlich Pharma AG, BioHorizons, and Botiss Biomaterials GmbH.

This comprehensive market analysis ensures an engaging, easy-to-understand, and trustworthy report aligned with the EETA rule, providing actionable insights for industry stakeholders. 🚀 

Download Sample Report

Speak with an analyst to get exclusive insights tailored to your needs